Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Description
AdAlta Ltd. operates as a biotechnology company, discovers, develops, and commercializes protein based therapeutics. The company was founded in 2007 and is headquartered in Bundoora, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.04
Trade Value (12mth)
AU$6,931.00
1 week
0%
1 month
-4.55%
YTD
-16%
1 year
16.67%
All time high
0.38
EPS 3 yr Growth
-54.20%
EBITDA Margin
N/A
Operating Cashflow
-$5m
Free Cash Flow Return
-261.00%
ROIC
-267.00%
Interest Coverage
-60.90
Quick Ratio
2.40
Shares on Issue (Fully Dilluted)
558m
HALO Sector
Healthcare
Next Company Report Date
22-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
05 September 24 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
05 September 24 |
Cleansing Notice under Section 708A
×
Cleansing Notice under Section 708A |
02 September 24 |
Proposed issue of securities - 1AD
×
Proposed issue of securities - 1AD |
02 September 24 |
Transaction, investment facility update
×
Transaction, investment facility update |
30 August 24 |
Change in substantial holding
×
Change in substantial holding |
28 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
28 August 24 |
Annual Report to shareholders
×
Annual Report to shareholders |
28 August 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
21 August 24 |
Investor events and presentation
×
Investor events and presentation |
29 July 24 |
Quarterly Appendix 4C and Activities Report
×
Quarterly Appendix 4C and Activities Report |
23 July 24 |
Results of Meeting
×
Results of Meeting |
04 July 24 |
Notification regarding unquoted securities - 1AD
×
Notification regarding unquoted securities - 1AD |
18 June 24 |
Investor Webinar Invitations
×
Investor Webinar Invitations |
18 June 24 |
Change of registered address
×
Change of registered address |
17 June 24 |
Letter to Shareholders, Notice of EGM & Proxy Form
×
Letter to Shareholders, Notice of EGM & Proxy Form |
04 June 24 |
Change in substantial holding
×
Change in substantial holding |
03 June 24 |
Change in substantial holding
×
Change in substantial holding |
03 June 24 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
03 June 24 |
$1.9 million raised from exercise of 1ADOA options
×
$1.9 million raised from exercise of 1ADOA options |
30 May 24 |
Change in substantial holding
×
Change in substantial holding |
29 May 24 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
21 May 24 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
20 May 24 |
Investor presentation
×
Investor presentation |
14 May 24 |
Application for quotation of securities - 1AD
×
Application for quotation of securities - 1AD |
13 May 24 |
Cellular immunotherapy manufacturer secured - Cell Therapies
×
Cellular immunotherapy manufacturer secured - Cell Therapies |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.